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Introduction 
3-Substituted-3-hydroxyindolin-2-ones have gained much 
attention from organic and medicinal chemists since this motif 
constitutes a core structure of a number of natural products[1] and 
drug candidates,[2] such as convolutamydines,[3] diazonamides,[4] 
leptosin D,[5] 3’-hydroxyglucoisatisin,[6] witindolinone C,[7] TMC-
95,[8] celogentin K,[9] dioxibrassinin[10] (Figure 1), as well as several 
other pharmaceutically active compounds.[11] The biological 
activity of these compounds is derived from their substituted 
group at C-3 position as well as the absolute configuration of the 
stereogenic center.[1c] 
 
Figure 1. Representative examples of active molecules containing 3-
substituted-3-hydroxyindolin-2-ones as core structure. 
Therefore, the development of efficient and practical methods 
to synthesize such kind of compounds is of great importance and 
it is a current open area of research in asymmetric catalysis.[12] 
One of the most straightforward approaches to enantiopure 3-
substituted-3-hydroxyindolin-2-ones is a catalytic nucleophilic 
addition of appropriate nucleophiles to readily available isatins, 
giving access to interesting molecular architectures with chiral 
centers.[13] In many reported works an enantioselective organo- or 
a metal-catalyzed method have been used for the synthesis of 
these appealing structures. Herein, we would like to show 
representative examples of these catalytic strategies where an 
isatin derivative was a key reagent, reported since 2000. 
Asymmetric organocatalysis 
Enantioselective aldol reaction 
Aldol reaction is one of the most important and powerful method 
for C-C bond formation in organic synthesis, and its asymmetric 
version has been broadly developed in the last decade.[14] In this 
sense, catalytic enantioselective aldol reactions of aldehydes and 
ketones with isatins represent a direct approach to 3-alkyl-3-
hydroxyindolin-2-ones with a new chiral stereocenter. 
The first enantioselective aldol reaction of acetone (2) with N-
alkylated isatins 1 was described by Tomasini and co-workers in 
2005.[15,16] Final desired products 4 with a new stereocenter with 
(R)-configuration were obtained with quantitative yields and good 
enantioselectivities (73-77% ee) when 10 mol% of dipeptide H-D-
Pro-L-3-hPhg-OBn 3 was used as catalyst (Scheme 1). The 
reaction was performed with a high excess of acetone (90 
equivalents) to favor the solubility of catalyst in this polar medium. 
The absolute configuration of proline skeleton seems to be 
decisive for the sign of the enantiomeric excess, and an accurate 
choice of the amino acid moiety in the second position was also 
indispensable to optimize the results.[17] 
A synthetic application of this method was later used in the 
first enantioselective construction of (R)-convolutamydine A 
skeleton, a marine natural product,[3a] starting from 4,6-
dibromoisatin (Scheme 1).[18] Enantiomerically enriched (R)-5 
(50% yield, 97% ee) was obtained after elimination of the catalyst 
by filtration on silica, partial recrystallization in order to eliminate 
rac-5, and subsequent concentration of aqueous mother with a 
further recrystallization. 
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Scheme 1. Enantioselective aldol reaction of isatin derivatives 1 with acetone 
(2) catalyzed by dipeptide 3. 
In an additional study,[19] the same research group realized 
about the importance and influence of the presence of variable 
amounts of water in the previous explored cross-aldol reaction in 
terms of both reactivity and enantioselectivity. The results were 
consistent with earlier reported studies where small amounts of 
water could not only increase the reaction rate but also improve 
the enantioselectivity of the reaction,[20] whereas a large excess of 
water could be detrimental for the process.[21] 
After the first synthesis of (R)-convolutamydine A ((R)-5), the 
synthesis of the opposite enantiomer in high yield (99%, 45% 
after recrystallization) and moderate enantioselectivity (60% ee, 
87% ee after recrystallization) was reported by Xiao and co-
workers using L-proline-derived bifunctional organocatalyst 6.[22] 
Interestingly, the authors also examined the ability of this catalyst 
in the aldol reaction of isatins with non-symmetric ketones such 
as 2-butanone (7) (Scheme 2), and not only with acetone (2).[23] 
This process was also efficient, providing the aldol adducts 8 in 
excellent chemical yields (up to 99%) with good 
enantioselectivities (70-75% ee). The reaction exhibited high 
regioselectivity (up to 12:1, 8:9), and afforded the products of C–
C bond formation through the less substituted C1-position of 2-
butanone (7), as the major regioisomer 8, versus minor isomer 9. 
 
Scheme 2 Enantioselective aldol reaction of isatins 1 with 2-butanone (7). 
The authors hypothesized that the absolute (S)-configuration 
obtained in final adducts, in the case of reaction with acetone (2), 
could be governed by enantiofacial discrimination between the 
geometry of the active specie catalyst-enamine and the 
orientation of isatin, as represented in Figure 2. The proposal of 
the authors was consistent with previous transition state models 
where L-proline was involved.[24] 
 
Figure 2. Plausible TS model for aldol reaction using catalyst 6. 
Kočovský group disclosed that vicinal amino alcohols 
efficiently promoted the asymmetric cross-aldol reaction of isatins 
with acetone (2).[25] Leucinol (10) was identified as the most 
effective catalyst exhibiting excellent reactivity and 
enantioselectivity under the optimal reaction conditions. With this 
strategy, the synthesis of both enantiomers of convolutamydine A 
(5) was addressed using 20 mol% of L- or D-leucinol (10). More 
interesting was the uncommon mechanism envisioned by the 
authors to explain the role of the catalyst in the transition state of 
this process (Figure 3). 
 
Figure 3. Equilibrium to give oxazolidine 11 and proposed TS for aldol reaction 
using catalyst D-leucinol (10). 
The authors invoked the formation of oxazolidine 11 as the 
active specie in the catalytic cycle, and as a proof of fact the 
same effectiveness was accomplished performing the reaction 
with preformed compound 11. The key role of the hydroxy group 
in the catalyst was demonstrated with the use of O-methylated 
leucinol since poorer enantioselectivities were obtained under the 
same reaction conditions, which is also consistent with the 
required formation of oxazolidine 11. This also suggests that 
hydrogen bonding between the keto group of isatin 1 and the 
enamine specie could be a prerequisite for the highly 
enantioselective process, as represented in TS (Figure 3). 
N-(2-Thienylsulfonyl)prolinamide 12 was found to work as an 
efficient catalyst for the synthesis of various convolutamydine A 
derivatives by using only 0.5 mol%, the lowest catalyst loading 
used in this process.[26,27] In a premature explanation, the authors 
suggested the important role played by the amide proton in the 
enantioselectivity of the process and that the reaction 
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preferentially proceeds through the anti-trans-TS to give (R)-5, 
versus the syn-trans-TS, which would afford (S)-5 enantiomer 
and would be destabilized by steric repulsions as depicted in 
Figure 4. 
 
Figure 4. Proposed TS for the synthesis of (R)-convolutamydine A (5) using 
catalyst 12. 
Zhao and co-workers applied cinchona derivative 14 as an 
effective catalyst for the synthesis of 3-alkyl-3-hydroxyindolin-2-
ones 15 (Schemes 3).[28] They envisioned the possibility of 
generating an enolate from unactivated ketones with a basic 
moiety in the catalyst structure in order to favor the formation of 
the active specie. This method is complementary to the enamine-
based organocatalyzed aldol reactions developed using chiral 
secondary or primary amines,[29] and is appropriate in cases 
where the formation of the enamine could be difficult. Between 
the remarkable results obtained, acetophenone was used as 
nucleophile in this asymmetric aldol reaction with isatins for the 
first time, and excellent results were also reached for ,-
unsaturated ketones.  
 
Scheme 3. Cinchona derivative 14 catalyzed enantioselective aldol reaction of 
isatins 1 with ketones 13. 
According to the obtained results a possible mechanism is 
proposed in Figure 5.[30] The first step would be the formation of 
the enamine by deprotonation with the tertiary amine in the 
catalyst backbone. On the other hand, the catalyst could play a 
dual role activating the isatin by two hydrogen bonds formed with 
the thiourea moiety, which would also direct the approach of 
isatin to the enolate. Among the two possible orientations of isatin 
depicted in Figure 5, the re face orientation is favored avoiding 
the steric interaction between the isatin benzene ring and the 
enolate in the TS2. Moreover, TS1 would lead to the observed 
major (R)-enantiomer. 
 
Figure 5. Proposed TS for the aldol reaction of isatin and acetone (2) with 
cinchona derivative catalyst 14. 
Synthesis of 3-cycloalkanone-3-hydroxy-2-oxindoles 16 is 
highly desired for medicinal chemistry because of their potential 
biological activity.[31] Recently, heterogeneous organocatalyst 
chitosan 17, used as green and recyclable catalyst, has been 
introduced to afford, by the first time, direct asymmetric aldol 
reaction in water between cyclohexanone and isatin with 
moderate results (Figure 6).[32] However, better results were 
achieved with primary-tertiary diamine-Brønsted acid catalyst 
18/TFA (10 mol%) introduced as an efficient promoter to give 3-
cyclohexanone-3-hydroxy-2-oxindoles 16.[33] Cyclohexanone was 
also explored in the catalytic asymmetric aldol reaction with 
isatins using carbohydrate-derived amino alcohol 19 as catalyst 
(Figure 6).[34] In that report, the reaction of various isatins with 
acetone, acetophenone and cyclohexanone was investigated 
under the optimal reaction conditions. According to the obtained 
results, the primary amino group of the catalyst was found to be 
very important for the activity and selectivity of the reaction. 
 
Figure 6. Catalysts 17-19 used for the synthesis of 3-cyclohexanone-3-hydroxy-
2-oxindoles 16. 
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Nakamura’s group applied prolinamide 12 in the first 
enantioselective aldol reaction between linear aldehydes 20 and 
isatins 1 affording final adducts 21 with high yields and 
enantioselectivities (Scheme 4).[35] The efficacy of the developed 
methodology was successfully demonstrated achieving the first 
enantioselective synthesis of convolutamydine E (22), and the 
synthesis of enantiopure convolutamydine B (23), reached by a 
subsequent derivatization of 22 (Scheme 4). 
 
Scheme 4. Synthesis of enantiopure convolutamydine E (22) and 
convolutamydine B (23). 
Independently, Wang and co-workers disclosed the reactivity 
shown with -branched aldehydes 24 in the same cross-aldol 
reaction with isatins,[36] complementing in this way the previous 
reported work using lineal aldehydes (Scheme 5).[35] Various 
chiral catalysts were examined in the preliminary screening to 
explore the viability of the process and among them (S)-
pyrrolidinetetrazole 25 afforded desired product 26 with promising 
results. 
 
Scheme 5. (S)-Pyrrolidinetetrazole 25 catalyzed cross-aldol reaction of isatins 1 
with -branched aldehydes 24. 
In the same context, Hayashi and co-workers[37] introduced 4-
hydroxydiarylprolinol 27 as an efficient catalyst for asymmetric 
aldol reaction of isatin derivatives with acetaldehyde. The reaction 
was performed in DMF in the presence of ClCH2CO2H as 
additive.[38] The obtained chiral diols 28 were key synthetic 
intermediates in the preparation of some natural products such as 
convolutamydine E (22), indole fragment of madindoline A and B 
(29),[39] and CPC-1 (30)[40] (Figure 7). 
 
Figure 7. Natural products synthesized from fragment 28. 
According to the obtained results, the authors suggested that 
the proton of the hydroxy group of the diarylmethanol moiety in 
catalyst 27 could coordinate the carbonyl group of isatin 1 
through modes A and B depending on the substituent in the isatin 
molecule and explaining in this sense, the enantioface selection 
observed (Figure 8). That is, when the substituent at C5 of isatin 
is small, mode A would be suitable affording the (R)-isomer, but 
in case of a larger substituent like a bromine atom, mode B would 
be favorable obtaining (S)-isomer. 
 
Figure 8. Coordination modes of OH catalyst 27 to isatin derivatives 1. 
For a synthetic pathway to obtain 3-hydroxyoxindoles 32 with 
a gem-difluoro-methylene group that can increase the lipophilicity, 
metabolic stability and bioavailability of the compounds,[41] Zhou 
group reported the first organocatalytic enantioselective aldol 
reaction route between difluoroenoxysilane 31 and isatin 1, using 
THF as solvent at 0 °C (Scheme 6).[42] 
Between the different bifunctional (thio)urea catalysts 
examined, the best results were reached with quinine derived 
urea catalyst 33 affording final products 32, in most cases, with 
very good enantioselectivity (88-95% ee). Here, urea catalyst 33 
plays a dual role in the acceleration of the reaction; (1) activating 
the difluoroenoxysilane 31 by the tertiary amine in the quinine 
backbone, (2) activating isatin 1 by the urea part of the catalyst 
through H-bonding interaction as shown in Figure 9. 
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Scheme 6. Aldol reaction of isatins 1 and difluoroenoxysilane 31 in the 
presence of bifunctional urea catalyst 33. 
 
Figure 9. Proposed TS for aldol reaction using urea catalyst 33. 
Remarkably, this protocol was efficiently used for the 
synthesis of the difluoro analogues of convolutamydine 34-37, 
with even greater biological activities, using catalyst 14 (Scheme 
7). 
 
Scheme 7. Synthesis of difluoro analogues of convolutamydine 34-37. 
Enantioselective MoritaBaylisHillman reaction 
The MoritaBaylisHillman (MBH) reaction is one of the most 
synthetically useful reactions between the -position of an 
activated alkene and a carbonyl group of aldehyde or ketone, in 
the presence of nucleophilic catalyst for producing multifunctional 
molecules, which are important intermediates in a wide variety of 
fields.[43] 
The enantioselective version of this reaction for aldehydes 
and imines has been explored using different catalysts such as 
chiral amines[44] and phosphines.[45] However, the use of activated 
ketones as suitable electrophile for this reaction has been less 
investigated,[46] even when MBH products from ketones such as 
isatin would allow the preparation of chiral tertiary alcohols, which 
are useful building blocks and valuable synthetic intermediates.[47] 
The first organocatalytic enantioselective example of this 
reaction was reported by Zhou and co-workers in 2010. They 
employed Hatakeyama’s catalyst, -iso-cupreidine 38 in an 
elegant reaction between isatins 1 and acrolein (39) leading to 3-
substituted-3-hydroxy-2-oxindoles 40 in very good yield (up to 
97%) and with excellent enantioselectivities (up to 98% ee) 
(Scheme 8).[48] The aldehyde group present in final products 40 is 
valuable for further synthetic transformations. 
 
Scheme 8. Enantioselective MBH reaction catalyzed by -iso-cupreidine 38 
using acrolein 39. 
After this pioneering example, -iso-cupreidine catalyst 38 
has also displayed remarkable catalytic effect in two similar 
methodologies directed toward the synthesis of MBH adducts 42 
and 44 by reaction of isatins 1 with 1-naphthyl (41)[49] or benzyl 
(43)[50] acrylate respectively, in high yields and with excellent 
enantioselectivities (Scheme 9). Remarkably, opposite absolute 
configuration in final products 42 and 44 is observed using the 
same enantiomeric form of the catalyst 38. 
 
 6
Scheme 9. Enantioselective MBH reaction of isatins 1 with acrylates 41 and 43 
catalyzed by -iso-cupreidine 38. 
In order to explain the enantioselectivity obtained in the final 
products and to gain insight into the mechanism of this process, 
Lu and co-workers investigated the potential role played by the 
C6'-OH of -ICD 38. Thus, -isocinchonine without the free 
phenolic hydroxy group was prepared and applied in the reaction. 
The results indicated that the C6'-OH group is critical for inducing 
excellent enantioselectivity and can contribute to the overall rate 
of the reaction. In the proposed mechanism depicted in Scheme 
10 -ICD 38 shows two vital roles: (1) nucleophilic addition of -
ICD to the acrylate acting as Lewis base catalyst, (2) stabilizing 
the transition state by facilitating the proton transfer step via its 
participation in an intramolecular proton relay process with the 
isatin (intermediate 46). 
 
 
Scheme 10. Plausible mechanism of MBH reaction in the presence of -ICD 38. 
Chiral phosphines have been also used as catalysts for this 
reaction. For example, Wu and co-workers used phosphine-
thiourea 48 and phosphine-squaramide 49, acting both as 
bifunctional catalyst through nucleophilic activation by the tertiary 
phosphine moiety and electrophilic activation by hydrogen-
bonding with NH groups of the thiourea and squaramide.[51] 
Although, lower enantiomeric excesses (up to 69% ee) were 
obtained in comparison with those previously reported, 3-
hydroxyl-2-oxindole derivatives 51 were obtained in excellent 
yields (up to 99%) in the presence of 10 mol% of catalyst 48 
(Scheme 11). More recently, the same research group designed 
a new chiral bifunctional phosphine organocatalyst to extend the 
study of this MBH reaction.[52] Novel organocatalyst 49 bearing 
squaramide moiety as H–bond donor instead of a thiourea group, 
was confirmed to be efficient for this process, leading to high 
yields (up to 99%) and appealing enantioselectivities (up to 99% 
ee after recrystallization) in the presence of a very low catalytic 
charge (2 mol%) although with longer reaction time (Scheme 11). 
 
 
Scheme 11. MBH reaction catalyzed by phosphine-thiourea 48, and phosphine-
squaramide 49. 
Enantioselective Friedel–Crafts reaction 
The use of FriedelCrafts alkylation reactions has received 
considerable attention for preparation of highly functionalized 
aromatic compounds by C–C and C–N bond formation, which can 
produce important building blocks for pharmaceutically applicable 
compounds.[53] To form optically active compounds based on 
FriedelCrafts alkylation reactions, different research groups have 
reported various chiral catalysts such as chiral Lewis acids,[53a,b,e] 
chiral Brønsted acids[53c] based on non-covalent interactions 
between catalyst and reagents, and chiral primary or secondary 
amines,[53d,f] based on covalent interactions to form an iminium 
intermediate. 
Although one of the most studied enantioselective 
approaches for the synthesis of 3-substituted-3-hydroxyindolin-2-
ones involves asymmetric Friedel–Crafts reaction with isatins, 
scarce organocatalytic methods have been reported so far in the 
literature for this purpose.[54] The first enantioselective synthesis 
of 3-hydroxyoxindoles via this approach was developed by Wang, 
Li and co-workers in 2010 using isatin 1 and indole 52 as 
nucleophile in the presence of cupreine (53) as promising catalyst, 
under mild reaction conditions.[55] It is noteworthy that integration 
of an indole moiety into an oxindole scaffold produces 3-indolyl-3-
hydroxy-2-oxindole 54 that are promising substrates for the study 
of their biological activity, as well as useful synthetic 
intermediates for drug candidates and alkaloids (Scheme 12).  
 
 
Scheme 12. Enantioselective Friedel–Crafts reaction of isatins 1 with indoles 52 
catalyzed by cupreine (53). 
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The feasibility of the process was examined with various 
catalysts, between them diverse cinchona alkaloids. From the 
results was envisioned that 6'-OH group on the cinchona skeleton 
played an important role in determining the stereochemical 
course and the rate of the reaction. This fact was confirmed by 
comparison of catalysts without the 6'-OH group in the structure, 
or with a 6’-OMe moiety, with the cupreine (53), which afforded 
the best results. In order to explain the observed stereochemistry 
a tentative transition state is proposed in Figure 10, where 
catalyst 53 plays a dual function in the activation of substrates. 
On one hand, both OH groups (6’ and 9) would interact with the 
carbonyl groups of isatin, while the quinuclidine tertiary amine 
would drive the indole for the attack over the re face of the ketone 
moiety of the isatin, delivering product 54 with (S)-configuration, 
determined by single crystal X-ray analysis. 
 
Figure 10. Proposed model for the cupreine (53) catalyzed enantioselective 
Friedel–Crafts alkylation reaction. 
At the same time, Chimni and co-workers published a 
successful organocatalytic asymmetric FriedelCrafts alkylation 
reaction for the synthesis of optically active 3-indolyl-3-hydroxy-2-
oxindoles 54 under very mild reaction conditions.[56] They 
employed BnO-cupreine 55, and were able to achieve a group of 
eleven synthetically useful 3-indolyl-3-hydroxy-2-oxindoles 54 in 
excellent yields (up to 99%) and high enantioselectivitiy (up to 
99% ee). It appeared that the electronic effects in isatins as well 
as in indoles had limited influence on the yield and 
enantioselectivity of the products. Based upon the observed 
results, the authors established a ternary complex transition state 
similar to the one in Figure 10 where the catalyst would play a 
dual role by simultaneous activation of both reactants, indole 52 
and isatin 1, by the quinuclidine moiety and the acidic 6’-OH 
group of the catalyst 55 (Figure 11). 
 
Figure 11. TS model for BnO-cupreine 55 catalyzed enantioselective Friedel–
Crafts reaction. 
Enantioselective Henry reaction 
The catalytic asymmetric nitroaldol reaction, also known as 
the Henry reaction, is an efficient method for the synthesis of 
chiral -nitroalcohols, which are valuable building blocks in 
organic synthesis.[57] To date, both chiral organocatalysts[58] and 
chiral metallic complexes have been developed efficiently for this 
reaction.[59] Although aldehydes have been successfully used as 
substrates in the asymmetric Henry reaction, the use of isatin 
derivatives has not been extensively explored as Henry acceptors 
for the enantioselective construction of quiral centers,[13,60] due to 
their strong tendency to retro-nitroaldol reaction under basic 
conditions.[61] 
Wang and co-workers reported in 2011 the first 
organocatalytic asymmetric Henry reaction of isatins in presence 
of natural cupreine (53) under mild reaction conditions (Scheme 
13).[62] As revealed from the experimental results, the process 
proved to be a general strategy for the synthesis of useful chiral 
3-substituted-3-hydroxy-2-oxindoles 57 with significant structural 
variations. Remarkably, in all cases, the reactions proceeded very 
fast, with excellent yields (99% in all cases), without purification 
by chromatography, and with good to high enantioselectivities 
(74-93% ee). 
 
Scheme 13. Cupreine (53) catalyzed enantioselective Henry reaction. 
As in previous proposed transition states both the 6'-OH and 
9-OH groups of 53 were essential for the stereocontrol of the 
reaction. Proposed transition state (TS) model supports the high 
enantioselectivity provided by cupreine (53) catalyst in this Henry 
reaction between isatin 1 and nitromethane acting in a dual 
faction (Figure 12). Bifunctional catalyst 53 activates 
nitromethane through the quinuclidine amine group and enables 
the activation of isatin through double-hydrogen-bonds with the 
6'- and 9-OH groups to deliver product 57 with a high level of 
enantioselectivity and with the observed absolute (R)-
configuration.  
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Figure 12. Proposed TS for cupreine 53 catalyzed Henry reaction. 
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To illustrate the synthetic utility of this methodology, the first 
asymmetric total synthesis of (S)-()-spirobrassinin 60, a natural 
product which displays various biological properties, was reached 
in four steps from 57 as shown in Scheme 14. 
 
Scheme 14. First asymmetric total synthesis of (S)-()-spirobrassinin (60). 
Independently, a similar work was reported by Wang and co-
workers.[63] They described the asymmetric Henry reaction of 
isatins with nitromethane promoted by a series of bifunctional 
catalysts based on cinchona alkaloid scaffold, among those C9-
3,5-(CF3)2-benzoylcupreine 61 with electron-withdrawing 
substituent was chosen as the most efficient and promising 
catalyst to deliver desired Henry adducts 57 with excellent yields 
(up to 97%) and high enantioselectivities (up to 92% ee) (Figure 
13). This catalytic strategy was further applied in the total 
synthesis of (R)-(+)-dioxibrassinin (59) and (S)-()-spirobrassinin 
(60). 
 
Figure 13. Catalysts 55, 61-62 used in the enantioselective Henry reaction of 
isatins 1 with nitroalkanes 56. 
The viability of an additional nitroaldol reaction between 
isatins and nitromethane was demonstrated by using BnO-
cupreine 55 as an acid–base bifunctional catalyst for providing 
final 3-hydroxy-3-(nitromethyl)indolin-2-ones 57 with good yields 
(90-98%) and good to high enantioselectivities (72-95% ee) 
(Figure 13).[64] Biscinchona alkaloid 62 was also employed as 
active catalyst in a simple protocol to promote the same reaction. 
Final Henry adducts 57 were obtained with high yields (up to 
98%) and high enantioselectivities (up to 97% ee) (Figure 13).[65] 
Enantioselective Strecker reaction 
Cyanation of imines, known as the Strecker reaction is a 
powerful strategy to obtain -amino nitriles.[66] Even today, after 
more than 160 years, this reaction attracts much attention from 
chemists, mainly because this reaction represents a direct and 
simple approach for the construction of -amino acids.[67] Since 
the first report of a catalytic enantioselective Strecker reaction in 
1996,[68] the enantioselective version of this reaction has been a 
very interesting topic in organic chemistry and great progresses 
have been accomplished in both fields, metal catalysis[69] and 
organocatalysis.[70] However, catalytic enantioselective Strecker 
reactions using ketimines as substrates are very limited and only 
one example has been reported regarding isatin.[71] 
Zhou and co-workers reported the first enantioselective 
Strecker reaction of isatins derived ketimines 63 with trimethylsilyl 
cyanide (TMSCN), promoted successfully by bifunctional 
cinchona alkaloid-based phosphinamide catalyst 64 (Scheme 
15).[72] Under the best reaction conditions, a number of ketimines 
63 were examined to give -amino nitriles 65 with moderate to 
good yields (up to 72%) and enantioselectivities (up to 74% ee). 
 
Scheme 15. First enantioselective Strecker reaction of ketimines 63 with 
TMSCN catalyzed by cinchona alkaloid-based phosphinamide 64. 
Enantioselective Pictet–Spengler reaction 
The PictetSpengler (PS) reaction is an acid catalyzed cyclization 
between a tryptamine derivative and an aldehyde.[73] This 
condensation has been of pivotal importance in the synthesis of 
numerous tetrahydroisoquinolines and tetrahydro--carbolines 
that are core structure elements in natural and synthetic organic 
compounds possessing a wide diversity of important biological 
activities.[74] 
Moreover, in recent years, there has been a considerable 
growth of interest in the synthesis of spirooxindole derivatives 
because of the wide-ranging biological activity associated with 
them, such as antibacterial, antifungal, antiinflammatory, and 
antipyretic activities (Figure 14).[12b,75] 
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Figure 14. Examples of biologically active spirooxindoles. 
In this context, the first access to this class of compounds in 
an enantioselective manner through a PictetSpengler strategy 
was acomplished by Bernardi and co-workers with a chiral 
Brønsted acid catalyzed reaction between isatins 1 and 
tryptamines 66 (Scheme 16).[76] The viability of the method was 
explored with several (S)-BINOL derived phosphoric acids with 
different substituents at the 3 and 3' positions to afford tetrahydro-
-carbolines 68. The results showed that 3,3'-substituents on 
binaphthyl system strongly influenced the enantioinduction of the 
process. Therefore, the most competent catalyst was the 
triisopropylphenyl-substituted phosphoric acid 67 giving easy 
access to optically active spiroindolinones 68 with excellent 
enantioselectivities (up to 95% ee) and high yields (68-97%). 
 
Scheme 16. Enantioselective catalyzed PS reaction by triisopropylphenyl-
substituted (S)-BINOL phosphoric acid 67. 
In a similar study, Franz and co-workers proposed that the 
phosphoric acid (HA*) promoted the reaction through an iminium 
ion intermediate that is capable of forming an iminium–phosphate 
ion pair 69 after the condensation between the tryptamine 66 and 
the isatin 1 (Scheme 17).[77] Intramolecular nucleophilic attack of 
the indole from its 2-position would lead to spirocyclization and 
formation of the new chiral carbon center. Finally, the resulting 
indolenium ion 70 undergoes an elimination to reestablish the 
aromaticity of the system, generating spiroindolone 68 and 
regenerating the catalyst (HA*).  
 
 
Scheme 17. Plausible spirocyclization mechanism in the presence of chiral 
phosphoric acid (HA*). 
Enantioselective hydrophosphonylation reaction 
Chiral -hydroxyphosphonates have recently received significant 
attention due to their biological and physical properties, as well as 
their utility as synthetic intermediates.[78] The reaction of 
aldehydes or ketones with dialkyl or trialkylphosphites in the 
presence of acidic or basic catalysts is the most frequently used 
approach for the synthesis of this class of compounds.[79] 
However, and in spite of the interest of the resulting backbones, 
asymmetric phospho-aldol reaction using isatin have not drawn 
much attention.[80] 
Only one successful enantioselective example of phospho- 
aldol reaction has been recently reported by Xu, Wang and co-
workers (Scheme 18).[81] Between all catalysts examined in this 
reaction, commercially available quinine (72) led to promising 
results being the catalyst of choice for further investigations and 
to explore the scope of this pioneering process. Thus, under the 
optimal conditions the enantioselective hydrophosphonylation 
reaction of diphenylphosphite (71) with N-alkylated isatin 
derivatives 1 was carried out affording chiral -
hydroxyphosphonates 73 in good to excellent yields (60-90%) 
and moderate to good enantioselectivities (25-67% ee). 
N
O
O + P
OPh
OPh
O
H
72 (20 mol%)
CH2Cl2, 0 oC N
O
P(O)(OPh)2HO
*
11 examples
60-99% yield
25-67% ee
1
R1
R2
R1
R2
71 73
HO N
H
N
MeO
72R1 = H, Me, F, Cl, Br
R2 = Me, Et, Bn, BrCH2CH2,
CH2=CHCH2
 
Scheme 18. Quinine (72) catalyzed enantioselective hydrophosphonylation 
reaction. 
According to the experimental results, a possible transition 
state involving a ternary complex between N-methylisatin 1, 
diphenylphosphite (71) and the catalyst 72 was suggested, as 
represented in Figure 15. As reflected in this model, the carbonyl 
group of isatin would be activated by the OH group of quinine (72) 
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through H-bond interaction, and at the same time the phosphite 
would be activated by the quinuclidine amine group. The dual role 
played by the catalyst in a synergic effect would control the attack 
of the phosphite (71) over the isatin 1, releasing the final product 
73. 
 
Figure 15. Proposed TS for the quinine-catalyzed phospho-aldol reaction. 
Asymmetric metal catalysis 
Metal catalyzed enantioselective Friedel–Crafts reaction 
In 2009, for the first time, Franz and co-workers employed chiral 
scandium(III) and indium(III) complexes in the development of a 
direct method for enantioselective and regioselective addition of 
indole and other nucleophiles to isatins 1 (Scheme 19).[82] The 
results demonstrated that between the chiral ligands explored the 
use of the inda-pybox ligand led to high enantioselectivity with 
several metals. Either scandium(III)-inda-pybox 74 or indium(III)–
inda-pybox 76 catalysts were found to afford products 75 with 
excellent yields and enantiomeric excesses for a variety of 
substituted isatin electrophiles and various electron-rich 
nucleophiles. However, better results were reached in general 
with scandium(III) complex 74 compared with indium(III) complex. 
+
4 Å MS, MeCN or CH2Cl2,
20 ºC or 40 ºC
Sc(OTf)3–inda-pybox (74) (5 mol%)
Nu
N
O
Me
N
O
R2
Br
1 75
73-99% yield
87-99%ee
87% yield
97% ee
90% yield
80% ee
82% yield
94% ee
84% yield
95% ee
N
N
OO
N Sc
OTf
TfO OTf
N
O
OHNu
R2
R1
N
O
R2
R1
O
74
OH
R1
OH
O
N
O
Me
Br
OH
N
O
Me
Br
OH
Ph
O
OMe
N
O
Me
Br
OH
NH2
OMe
N
X
R3
 
Scheme 19. Sc-catalyzed enantioselective Friedel–Crafts reaction of isatins 1 
with a variety of nucleophiles. 
Significantly, a recent study by the same group has been 
focused on the application of indium(III)-inda-pybox complex 76 in 
the first catalytic addition of pyrrole 77 to isatin derivatives 1 with 
excellent enantioselectivities (up to 99% ee) and yields (up to 
98%) (Scheme 20).[83] It is worth noting that ee values were 
sensitive to metal and solvent effects, as well as the electronic 
and steric substitution pattern of both coupling partners.  
 
Scheme 20. Enantioselective addition of pyrrole 77 in the presence of chiral 
indium(III)-inda-pybox complex 76. 
Vinylogous Mannich reaction 
Early research into vinylogous Mannich reaction[84] showed that it 
has acquired increasing attention as a powerful tool for CC bond 
formation for synthesis of highly functionalized -amino 
compounds. Although the first asymmetric vinylogous Mannich 
reaction of trimethylsilyloxyfuran (TMSOF) to -ketimine esters 
was developed in 2009 with high enantioselectivity,[85] only 
recently Deng and co-workers has reported a diastereoselective 
catalytic variant of this reaction using isatin-based ketimine 63 
and TMSOF (79) by employing AgOAc to promote the reaction 
pathway for the synthesis of 3-aminooxindoles 80 that is a 
frequent core unit in natural products (Scheme 21).[86] 
 
Scheme 21. AgOAc-catalyzed vinylogous Mannich reaction of 63 and 79. 
The ability of AgOAc to promote this reaction compared to 
other metal salts, such as copper, zinc or nickel, was higher 
leading to the desired products 80 with excellent yields (94-99%) 
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and complete anti-diastereoselectivity (>99:1) under very mild 
conditions. The authors invoked a transition state based on the 
well-known bifunctional capacity of this specie to explain the 
relative configuration observed in the final products 80 (Scheme 
21). In this plausible transition state, Ag(I) is coordinated as Lewis 
acid to 2 equivalents of substrate, and acts also as base after 
coordinating to TMSOF (79) and releasing OAc, which is real 
base to capture the TMS group and consequently promoting the 
attack of TMSOF (79) over the isatin 1. 
Metal catalyzed enantioselective alkenylation, arylation and 
allylation 
Metal catalyzed addition of arylboronic acids  
Most of the reported routes for catalytic enantioselective addition 
of organometallic nucleophiles to -dicarbonyl substrates have 
been limited to alkynyl[87] or alkyl zinc reagents.[88] However, in 
2006 Vries, Feringa, Minnaard and co-workers provided a general 
method using the combination of rhodium-catalyst and a variety 
of arylboronic acids 81 to synthesize 3-aryl-3-hydroxyoxindoles 
82, in pronounced high yields (up to 99%) (Scheme 22).[89] Only 
an asymmetric example have been reported, obtaining moderate 
enantioselectivity with chiral ligand L1 (55% ee, 94% ee after 
recrystallization). 
 
Scheme 22. Rh-catalyzed enantioselective addition of aryl- and alkenylboronic 
acids 81 to isatins 1. 
In addition, in this protocol electron-donating groups on the 
isatin substrate decreased the reactivity (yield 62%), while 
electron-donating substituents on the boronic acid improved the 
reactivity (yield 99%). Authors proposed a plausible mechanism, 
where alkoxy species 85 resulting from the arylation of the 
carbonyl function, is believed to act as a nucleophile in the 
transmetalation step to regenerate the catalytic active 
intermediate 83 (Scheme 23).[90] 
 
Scheme 23. Proposed mechanism of the Rh-catalyzed 1,2-addition of 
arylboronic acids 81 to isatins 1. 
Independently, Hayashi and co-workers described a more 
general methodology of this reaction using Rh/(R)-MeO-mop (L2) 
complex catalyst for the addition of arylboronic acids 81 to isatins 
1 under mild conditions, achieving high enantioselectivity (up to 
93% ee) (Scheme 24).[91] 
 
Scheme 24. Rh-catalyzed chiral addition of arylboronic acids 81 to isatins 1. 
Between the diverse chiral phosphine ligands tested, (R)-
MeO-mop (L2), an axially chiral mono-phosphine ligand, gave 
remarkable higher yields and significantly improved the 
enantioselectivity (92% yield, 90% ee) for various arylboronic 
acids 81 and different N-protected isatin derivatives 1. Moreover, 
the authors were able to extend their protocol to alkenylboronic 
acids for the synthesis of tertiary allylic alcohol derivatives in 
excellent yield and with high ee values (91–98% yield, 88–93% 
ee). 
In 2009, an example of chiral Pd-complex was also disclosed 
to catalyze the asymmetric addition of arylboronic acids 81 to N-
benzylisatin 1 with moderate yields and enantioselectivities 
(Scheme 25).[92,93] The ability of various Pd-salts with different 
new synthesized chiral biaryl-phosphino-sulfinyl imine ligands for 
promoting the arylation reaction was explored. The most 
promising results were achieved using combination of 
Pd(OAc)2/L3 and BF3·Et2O as a Lewis acid to improve the 
reactivity of isatin, affording tertiary alcohols 87 with moderate 
enantioselectivities. 
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Scheme 25. Pd-catalyzed asymmetric addition of arylboronic acids 81 to isatins 
1. 
On the basis of the results, it was observed that the absolute 
configuration of final product was controlled by the axial chirality 
of the ligands rather than the sulfinyl group chirality. 
Metal catalyzed addition of arylsilanes and alkenylsilanes 
Although many methods for the synthesis of optically active 3-
aryl-3-hydroxy-2-oxindoles have been developed, none of them 
has allowed the synthesis of a highly active non-peptidic growth 
hormone secretagogue SM-130686 (90) because of a bulky 
group on C4 position (Scheme 27). In 2009, the discovery of a 
highly efficient enantioselective synthesis of 3-aryl-3-hydroxy-2-
oxindoles 89 was published based on Cu-catalyzed alkenyl- or 
arylation of isatin 1 by silanes reagents 88 (Scheme 26).[94,95] This 
reaction was applied to isatin substrates 1 and a variety of aryl- 
and alkenylsilanes 88 in the presence of Cu-catalyst and optimum 
chiral ligand L4 for generating reactive aryl- or alkenyl-copper 
species by transmetalation from the stoichiometric silicon-based 
reagents. Catalytic fluoride additives (such as TBAT or PhBF3K) 
improved the reactivity without affecting the enantioselectivity. 
The DMTr (dimethoxytrityl) protecting group of 89 was further 
removed easily with 10% TFA in CH2Cl2 in the presence of p-
anisole in high yield without any racemization. 
N
O
O +
N
O
2) TBAF
1) CuF·3PAr3·2EtOH (x mol%)
L4 (1.4x mol%)
ZnF2 (3x mol%), toluene, 25 ºCR2-Si(OMe)3
R2HO
up to 98% yield
up to 97% ee
881 89DMTr
N
O
PAr2
Ar2P
Fe
MeMe
DMTr
Si(OMe)3
Si(OMe)3 Si(OMe)3
ClL4
Me Si(OMe)3
Si(OMe)3
88a
x = 10 (35 ºC)
88b
x = 5
88c
x = 5
88d
x = 10 (35 ºC)
88e
x = 5
Ar = 4-FC6H4
R1 R1
Ar = 3,5-xylyl
R1 = H, 5-Cl, 5-OMe, 5-Me, 6-Cl
 
Scheme 26. Cu-catalyzed enantioselective alkenylation and arylation of isatins 
1. 
The interest of this method resides in its application as a key 
step for the first catalytic synthesis of highly optically active SM-
130686 (90). To overcome the unsatisfactory efficiency of the 
previously shown intermolecular arylation addition in the 
synthesis of 90, the same authors developed a more efficient 
catalytic enantioselective intramolecular arylation of -keto 
amides 91 as an alternative strategy (Scheme 27).  
 
Scheme 27. Cu-catalyzed enantioselective intramolecular arylation in the 
synthesis of SM-130686 (90). 
Enantioselective iridium-catalyzed allylation, crotylation, and 
reverse prenylation of isatins 
Krische and co-workers have reported the first enantioselective 
allylation, crotylation, and reverse prenylation of isatins, with good 
yields and high enantioselectivities (Scheme 28).[96] In contrast to 
other classical allylation systems based on the use of 
stoichiometric quantities of allyl-metal reagents,[97] this method by 
isopropanol-mediated transfer hydrogenation, uses allyl acetate, 
-methyl allyl acetate, and 1,1-dimethylallene as precursors to 
transient allyl-, crotyl-, and prenyl-metal intermediates, 
respectively. The use of cyclometalated C,O-benzoate generated 
in situ from {Ir(cod)Cl}2, CTH-(R)-P-Phos (CTH-(R)-P-Phos = (R)-
(+)-2,2’,6,6’-tetramethoxy-4,4’-bis(diphenylphosphino)-3,3’-
bipyridine) and 3-nitrobenzoic acid derivatives, gave the best 
results. 
 
Scheme 28. Ir-catalyzed enantioselective allylation, crotylation and reverse 
prenylation of N-benzyl isatins 1. 
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Opposite absolute configuration is observed in the case of 
carbonyl reverse prenylations employing 1,1-dimethylallene 
respect to the corresponding allylations and crotylations. The 
authors proposed an analogous mechanism for carbonyl reverse 
prenylation (Scheme 29a),[98] through a chairlike transition 
structure and an (E)--crotyl iridium intermediate. Thus, in order 
to explain the different configuration is possible to propose that 
isatin crotylation occurs by way of the transition structure A, 
whereas isatin reverse prenylation occurs by way of the transition 
structure B (Scheme 29b), since nonbonded interactions of axial 
methyl group with the electron-deficient rim of the arene is 
presumably less destabilizing than nonbonded intermediate with 
the amide  bond of isatin. 
 
Scheme 29. Mechanism hypothesis. 
HosomiSakurai allylation of isatins 
The HosomiSakurai reaction involves the Lewis acid-promoted 
allylation of various electrophiles with allylsilane.[99] A short 
enantioselective version of this strategy was successfully applied 
by Zhou and co-workers for the asymmetric allylation of isatins, 
using 1 mol% of chiral mercury catalyst (S)-
BINAP/Hg(ClO4)2·3H2O in THF to yield the (S)-enantiomer of 
product 99 with excellent yield (up to 96%) and moderate 
enantioselectivities (up to 63% ee). This is the first example of 
catalytic asymmetric allylation of ketones using less reactive 
allyltrimethylsilane (98) (Scheme 30).[100,101] 
 
Scheme 30. Hg-catalyzed enantioselective allylation of isatins 1. 
Catalytic asymmetric [3+2] annulation of allylsilanes with 
isatins 
Catalytic asymmetric [3+2] annulation of allylsilanes with isatins 
has recently emerged by Franz and co-workers as a new route to 
afford silyl-substituted spirooxindoles 101 with excellent 
enantioselectivities (up to 99% ee), an important class of 
compounds with biological activities (Scheme 31).[102,103] 
 
Scheme 31. Sc-catalyzed [3+2] annulation of allylsilane 100. 
To optimize the reaction, diverse chiral Sc-complexes and 
various additives such as AgSbF6 and trimethylsilyl chloride 
(TMSCl) to enhance the reactivity of the catalysts were explored. 
Consequently, TMSCl as activator played a key role for the 
appropriate choice of the best catalyst system, and improving 
both rate enhancement and product ratio (between the competing 
annulation and allylation reactions). In all cases the desired 
product 101 was obtained in good yield (up to 82%) and excellent 
enantioselectivity (up to 99% ee). Although in this protocol both 
allylation and [3+2] annulation pathways can take place, several 
allylsilanes 100 with various steric and electronic properties were 
examined to identify an allylsilane that favored mainly the 
annulation pathway. In general, bulky silyl groups predominantly 
led to annulation pathways, and silyl reagents with aromatic 
moieties afforded allylation reaction, but with a “removable” 
aromatic moiety the silyl group of the resulting adducts can be 
easily converted into a hydroxy group under mild oxidation 
conditions (Scheme 32). 
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Scheme 32. Sc-catalyzed [3+2] annulation-allylation ratios (101:102) for 
allylsilanes 100.  
The authors demonstrated the utility of this protocol, 
synthetizing hydroxy-spirooxindoles 103 from easily oxidizable 
benzhydryl silyl group with TBAF and hydrogen peroxide. The 
reaction proceeds with high yields and retention of configuration 
(Scheme 33). 
 
Scheme 33. Enantioselective allylsilane annulation and CSi oxidation. 
After this pioneering example, the same group designed a 
catalytic enantioselective HosomiSakurai allylation and 
crotylation of isatins with various substituted allylic silanes 104 
using a Sc(III)-inda-pybox (L6) complex with TMSCl as activator 
and NaSbF6 as additive to achieve 3-allyl-3-hydroxy-2-oxindoles 
105 with high yields (up to 99%) and excellent enantioselectivities 
(up to 99% ee) (Scheme 34).[104] 
 
Scheme 34. Sc-catalyzed enantioselective HosomiSakurai allylation of isatins 
1. 
The peculiarity of this method is the possibility of carrying out 
the reaction using a very low catalyst loading (0.05 mol%) at 
room temperature, which makes it a useful protocol for synthetic 
intermediates and industrial applications. In fact, the scalability of 
this allylation reaction at low catalyst loading (0.1 mol%) was 
tested in a gram-scale reaction obtaining the same good results. 
The first metal-catalyzed diastereoselective total synthesis of 
convolutamydines B (23) and E (22) have been developed by 
Kobayashi and co-workers using vinylogous Mukaiyama aldol 
reaction in the presence of TiCl4 in CH2Cl2, at 78 °C (Scheme 
35).[105] 
 
Scheme 35. Diastereoselective total synthesis of (R)-convolutamydines B (23) 
and E (22). 
They examined different reaction conditions with different 
starting materials (Figure 16) for aldol reaction, and finally the 
vinylogous Mukaiyama aldol reaction by using compound ent-106 
showed the best yield (69%) and stereoselectivity (60:1). 
 
Figure 16. Typical nucleophiles for aldol reaction. 
This procedure afforded 107 in good yield (74%) with 
excellent diastereoselectivity (>99:1) and reproducibility. (R)-
convolutamydine E (22) and B (23) were obtained from the 
product of this reaction by simple transformations (Scheme 35).  
Asymmetric addition of alkyl enol ethers to isatin via ene 
reaction 
The asymmetric carbonyl-ene reaction is one of the simplest 
methods for C-C bond forming reactions to synthesize a 
stereogenic carbon atom.[106] However, the use of alkyl enol 
ethers as the ene component has been scarcely explored[107] 
because of the instability of these reagents in the presence of a 
Lewis acid and the probable competitive Mukaiyama aldol 
reaction versus ene pathway. 
Very recently, Feng and co-workers have reported the first 
catalytic enantioselective hetero-ene reaction of alkyl enol ethers 
112 with three kinds of 1,2-dicarbonyl compounds (including 
isatins, -ketoesters, and glyoxal derivatives) using the chiral 
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N,N’-dioxide L7 complex of Mg(OTf)2 under mild reaction 
conditions (Scheme 36).[108] It was confirmed by the results that 
electron-withdrawing substituents on isatin led to higher reactivity 
and enantioselectivity even with a catalyst loading of 1–5 mol% 
without producing the corresponding Mukaiyama aldol products 
114. It is worth noting that (R)-convolutamydine A (5) can be 
synthesized from 4,6-dibromo-isatin by this hetero-ene reaction 
with 87% yield and 97% ee. Moreover, this method has the 
distinction of providing a good variety of substrates, facile 
procedure, and mild reaction conditions in relation to previously 
reported methods for ene-carbonyl reaction. 
 
Scheme 36. Enantioselective addition of alkyl enol ethers 112 to isatin 1 via 
ene reaction. 
Metal catalyzed asymmetric synthesis of spirooxindoles 
The heterocyclic spirocyclic oxindoles are of great interest in 
organic synthesis because of their presence as core structure in 
natural products as well as their biological activity.[12,75] 
Very recently, Shintani, Hayashi and co-workers have 
reported the application of phosphoramidite ligand L8 as an 
efficient ligand with palladium to diastereoselective synthesis of 
spirooxindole derivatives 116 through decarboxylative [4+2] 
cyclization of -methylidene--valerolactones 115 with isatins 1 
(Scheme 37).[109] The results have demonstrated that a 
bis(diphenylmethyl)amino group on phosphorus ligand can 
improve the yield and diastereoselectivity of the corresponding 
spirooxindoles (d.r. up to 99:1). According to the proposed 
mechanism by this group, nucleophilic addition of 1,4-zwitterionic 
species 117 to isatins 1 and then ring closure of intermediate 118 
leads to desired products 116 in high yield with excellent 
diastereoselectivity (Scheme 38). 
 
 
Scheme 37. Pd-catalyzed decarboxylative [4+2] cyclization of -methylidene--
valerolactones 115 with isatin derivatives 1. 
 
Scheme 38. Proposed catalytic cycle for the palladium-catalyzed 
decarboxylative cyclization of isatins 1 with compound 115. 
They have also explored the asymmetric variant of this 
catalyst to control the relative and absolute stereochemistry of the 
two contiguous stereocenters. By employing chiral 
phosphoramidite L9 as ligand at 0 ºC, the reaction gives the 
corresponding spirooxindoles with high yields and excellent 
stereoselectivity (d.r. 88:12 to 95:5, major isomer 73-87% ee) 
(Figure 17). 
 
 
Figure 17. Asymmetric variant of Pd-catalyzed decarboxylative [4+2] cyclization 
of -methylidene--valerolactones 115 with isatin derivatives 1. 
Outlook 
Isatin derivatives have gained an emergent interest in the last 
years in organic and medicinal chemistry since they constitute the 
backbone of a great number of interesting compounds especially 
those derived from 3-substituted-3-hydroxyindolin-2-ones as core 
structure. We have collected in this review the most 
representative examples in the field of organocatalysis and metal 
catalysis, giving to the reader a broad vision of their pivotal role in 
asymmetric catalysis as a current open area of research and as a 
strategic motif for the construction of appealing structures. In this 
sense, a number of research groups have invested efforts in the 
development of different reactions where isatin is a key substrate 
and herein these strategies have been described. The synthesis 
of important natural products has been also discussed showing 
the application of the developed catalytic methodologies. 
However, we believe that this field is still in its infancy and we will 
assist to the development of more reactions concerning this 
molecule and their application in industry in the very near future. 
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